Ying Fan

机构：Hebei North University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, China International Science and Technology Cooperation, National Cancer Center, Shanghai Pulmonary Hospital, Shanghai Sixth People's Hospital, Children's Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0001-7638-2488

发表论文 165 篇 · 总被引 2577 次 · h-index 27

代表论文

• Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial (2025 · Nature Medicine · 被引 53)
• The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study (2025 · The Breast · 被引 9)
• Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study (2025 · Nature Communications · 被引 7)
• Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy (2024 · The Breast · 被引 5)
• Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer (2024 · Translational Oncology · 被引 4)
• Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial (2025 · The Breast · 被引 3)